Related Experiment Video
Updated: Jun 27, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Hypertension and heart failure: a dysfunction of systole, diastole or both?
1Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
Insights
Hypertension causes pathological myocardial hypertrophy, leading to systolic and diastolic heart failure. Addressing factors beyond heart muscle dysfunction, like chronotropic incompetence, may improve exercise capacity in these patients.
Area of Science:
- Cardiology
- Hypertension Research
- Heart Failure Studies
Background:
- Pathological myocardial hypertrophy in hypertension seeds maladaptive cardiac development.
- Factors like impaired coronary perfusion, fibrosis, and abnormal ventricular function contribute to systolic and diastolic dysfunction.
- Chronotropic incompetence and peripheral factors (vasodilator reserve, arterial compliance) impact cardiac output, especially during exercise.
Purpose of the Study:
- To explore the spectrum of heart failure in hypertensive patients, viewing distinct phenotypes as part of a continuum.
- To highlight the limitations of dichotomizing heart failure into systolic and diastolic entities, impacting clinical trial development.
- To identify potential therapeutic targets beyond cardiac dysfunction for improved patient outcomes.
Main Methods:
- Review of existing evidence on myocardial hypertrophy, ventricular remodeling, and functional abnormalities in hypertensive heart disease.
- Analysis of commonalities between hypertensive heart failure with normal ejection fraction and systolic heart failure.
- Examination of the role of chronotropic incompetence and peripheral vascular function in exercise capacity.
Main Results:
- Hypertensive heart failure encompasses a spectrum of ventricular remodeling and volume changes, not distinct entities.
- Many underlying pathological factors are shared across different heart failure presentations in hypertensive individuals.
- Current therapeutic approaches may be limited by focusing solely on systolic and diastolic dysfunction.
Conclusions:
- Hypertensive heart failure is a complex disorder involving more than just cardiac muscle function.
- Therapies targeting myocardial fibrosis, enhancing vasodilator reserve, and improving chronotropic incompetence warrant further investigation.
- Addressing peripheral factors and exercise response may lead to more effective treatments for hypertensive heart failure patients.
Abstract:
The pathological myocardial hypertrophy associated with hypertension contains the seed for further maladaptive development. Increased myocardial oxygen consumption, impaired epicardial coronary perfusion, ventricular fibrosis and remodelling, abnormalities in long-axis function and torsion, cause, to a varying degree, a mixture of systolic and diastolic abnormalities. In addition, chronotropic incompetence and peripheral factors such as lack of vasodilator reserve and reduced arterial compliance further affect cardiac output particularly on exercise. Many of these factors are common to hypertensive heart failure with a normal ejection fraction as well as systolic heart failure. There is increasing evidence that these apparently separate phenotypes are part of a spectrum of heart failure differing only in the degree of ventricular remodelling and volume changes. Furthermore, dichotomizing heart failure into systolic and diastolic clinical entities has led to a paucity of clinical trials of therapies for heart failure with a normal ejection fraction. Therapies aimed at reversing myocardial fibrosis, and targets outside the heart such as enhancing vasodilator reserve and improving chronotropic incompetence deserve further study and may improve the exercise capacity of hypertensive heart failure patients. Hypertension heart disease with heart failure is simply not a dysfunction of systole and diastole. Other peripheral factors including heart rate and vasodilator response with exercise may deserve equal attention in an attempt to develop more effective treatments for this disorder.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: Diuretics
Mitral Regurgitation I: Introduction
